pubmed-article:3107301 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3107301 | lifeskim:mentions | umls-concept:C0014137 | lld:lifeskim |
pubmed-article:3107301 | lifeskim:mentions | umls-concept:C0015915 | lld:lifeskim |
pubmed-article:3107301 | lifeskim:mentions | umls-concept:C0016434 | lld:lifeskim |
pubmed-article:3107301 | lifeskim:mentions | umls-concept:C0680229 | lld:lifeskim |
pubmed-article:3107301 | lifeskim:mentions | umls-concept:C1511572 | lld:lifeskim |
pubmed-article:3107301 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:3107301 | pubmed:dateCreated | 1987-5-26 | lld:pubmed |
pubmed-article:3107301 | pubmed:abstractText | Sixty-three patients treated with exogenous gonadotropins for a total of 232 non-IVF cycles were monitored by serum E2 and/or total urinary estrogen excretion. The endocrine profile of follicular phase during HMG-HCG stimulation was evaluated with regard to an effect on the pregnancy rate. Six different follicular phase patterns were observed: A-profiles (daily exponential increase of sE2 or total urinary estrogen values followed by a sustained exponential increase on the day after HCG injection) seem to be necessary to obtain pregnancy, being followed by conception in 21.5% of all cases. Other profiles have lower conception rate (10%); no conception occurred when non exponential E2 rise was observed. The different responses are not related to total dosage of HLG administered. Patients who were treated for hypogonadotropic hypogonadism had a high pregnancy rate (80%) even in absence of post-HCG estrogen rise (G-endocrine profiles. Women aged 35 years must have significantly higher doses of gonadotropins to obtain A-profiles. Monitoring by E2 seems to be more adequate than the TUE only (conceptual pregnancy rate/cycle of 15.25%, versus 10.34%). In conception cycle, midluteal E2/P ratio never exceeds 50. | lld:pubmed |
pubmed-article:3107301 | pubmed:language | eng | lld:pubmed |
pubmed-article:3107301 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3107301 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3107301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3107301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3107301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3107301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3107301 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3107301 | pubmed:issn | 0587-2421 | lld:pubmed |
pubmed-article:3107301 | pubmed:author | pubmed-author:GerrisJJ | lld:pubmed |
pubmed-article:3107301 | pubmed:author | pubmed-author:BuytaertPP | lld:pubmed |
pubmed-article:3107301 | pubmed:author | pubmed-author:DelbekeLL | lld:pubmed |
pubmed-article:3107301 | pubmed:author | pubmed-author:Van GaalLL | lld:pubmed |
pubmed-article:3107301 | pubmed:author | pubmed-author:DesmedtEE | lld:pubmed |
pubmed-article:3107301 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3107301 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:3107301 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3107301 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3107301 | pubmed:pagination | 251-8 | lld:pubmed |
pubmed-article:3107301 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:meshHeading | pubmed-meshheading:3107301-... | lld:pubmed |
pubmed-article:3107301 | pubmed:articleTitle | A lesson from IVF endocrinology: the importance of the follicular phase to success and failure in non-IVF cycles. | lld:pubmed |
pubmed-article:3107301 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3107301 | pubmed:publicationType | Comparative Study | lld:pubmed |